Connect with us

CBD News

Trulieve Performing Well in CBD Space as Cannabis Corp Sees Revenue of Nearly $58 Million in Q2

Judith Hayes



Trulieve Performing Well in CBD Space as Cannabis Corp Sees Revenue of Nearly $58 Million in Q2

Trulieve Cannabis Corp issued a press release on its second quarter of 2019 financial results and it appears that it is performing well in the CBD space.

According to the press release, a few of the second quarter highlights include that it recorded record revenue of $57.9 million, its patient growth in Florida grew by 19%, it completed a public debt offering raising $70 million in aggregate principal, and it also opened three more dispensaries in Florida.

Aside from these operational highlights, the company also launched automation initiatives to improve product output, innovation, and efficiencies, and it acquired a CT-based medical dispensary called The Healing Center.

Kim Rivers, Trulieve’s CEO, shared in the press release,

“Our strong financial results for the quarter combined with our operational and foundational evolution illustrates that Trulieve is not just a cannabis company, but an organization that possess the key fundamentals expected of leading companies across all industries,”

she continued.

“By continuing to focus on operational efficiencies, maintaining sound financial discipline, and leveraging our strong brand awareness and patient loyalty within current markets and in future expansion initiatives, we expect our efforts to translate to new strong results throughout the remainder of 2019.”

Judith Hayes lives in Maine and loves to visit Florida. She is a women of many talents and skills as her primary passion is freelance writing but is also a web designer, photographer and world traveller. Her experience in broadcast journalism is what led her into authoring several books as well as being a featured editor at the Journal of Health magazine. Judith enjoys writing about health, nutrition, vegetarianism, aging, lifestyle, technology and of course, cannabis and CBD.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *


Join Us On Facebook


Trending CBD News

TimesofCBD always fact checks sources and aims for the best accuracy in the reporting curated cannabis content consisting of the latest CBD news, user guides and product health research. Quality is the priority, but we are not eligible to be liable as everything here is for educational, informational purposes only. Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.

What Is CBD?